Skip to content
Home » Resources » 10 Key Recommendations for Enhancing Joint Clinical Assessments Under the EU HTA Regulation

10 Key Recommendations for Enhancing Joint Clinical Assessments Under the EU HTA Regulation

    10 Key Recommendations on Patient Involvement in EU HTA JCAs – CPE

    10 Key Recommendations for Enhancing Joint Clinical Assessments Under the EU HTA Regulation

    Publication format: Call to Action
    Year: 2024
    Topic: Advocacy, Health Systems & Care Delivery, Policy & Regulation
    Language: English
    View this resource

    This Call to Action, produced by Cancer Patients Europe and co-signed by European and national patient organisations, sets out ten evidence-based recommendations for ensuring meaningful and practical patient involvement in Joint Clinical Assessments (JCAs) under the EU HTA Regulation. The recommendations address predictable patient engagement frameworks, inclusion of patient experience data, streamlined involvement throughout the assessment process, plain language summaries, broadened patient recruitment, dedicated support for participants, translation of reports into all EU languages, structured feedback mechanisms, and constructive approaches to confidentiality and conflict of interest. The document draws on patient organisations’ practical experience with HTA processes across Europe.